Acesso livre
Acesso livre

Otorrinolaringologia/Cabeça e Pescoço

Estudo randomizado | Em pacientes com câncer de cabeça e pescoço submetidos a cirurgia, a quimioterapia com cisplatina semanal é não inferior à cisplatina a cada 3 semanas e está associada com toxicidade reduzida.

3 Mar, 2022 | 15:41h

Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial – Journal of Clinical Oncology

 

Comentário do autor no Twitter

 


Diretriz atualizada | Momento da cirurgia eletiva e avaliação de risco após infecção por SARS-CoV-2 – “Mantemos a orientação de que os pacientes devem evitar cirurgias eletivas dentro de 7 semanas da infecção, a menos que os benefícios superem o risco de aguardar por tal período.”

1 Mar, 2022 | 15:38h

Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update – Anaesthesia

Conteúdos relacionados:

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of Covid-19.

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19


Câncer orofaríngeo associado ao HPV: epidemiologia, biologia molecular e tratamento clínico.

1 Mar, 2022 | 15:03h

HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management – Nature Reviews Clinical Oncology (se o acesso a este link for pago, tente este)


Estudo randomizado | Momento da recuperação funcional após tonsilectomia a laser feita sob anestesia local vs. tonsilectomia convencional com anestesia geral em adultos.

22 Fev, 2022 | 15:12h

Time to Functional Recovery After Laser Tonsillotomy Performed Under Local Anesthesia vs Conventional Tonsillectomy With General Anesthesia Among Adults: A Randomized Clinical Trial – JAMA Network Open

 

Comentário no Twitter

 


Diretriz de consenso | Cuidados com os sobreviventes do câncer de cabeça e pescoço.

17 Fev, 2022 | 14:30h

Head and neck cancer survivorship consensus statement from the American Head and Neck Society – Laryngoscope Investigative Otolaryngology

Conteúdos relacionados:

Head and Neck Cancer Survivorship Care Guideline

American Cancer Society Head and Neck Cancer Survivorship Care Guideline


Tratamento do paciente pós-laringectomia no departamento de emergência.

14 Fev, 2022 | 15:38h

ED Management of the Post-Laryngectomy Patient – emDocs


Diretriz de consenso ETA | Quais são as indicações para terapia com iodo radioativo pós-cirurgia no câncer diferenciado de tireoide?

11 Fev, 2022 | 13:50h

2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? – European Thyroid Journal


Diretriz de prática clínica para uso de tubos de timpanostomia em crianças.

10 Fev, 2022 | 13:58h

Executive Summary of Clinical Practice Guideline on Tympanostomy Tubes in Children (Update) – Otolaryngology–Head and Neck Surgery


Atualização | Terapias para disfunções olfatórias.

7 Fev, 2022 | 13:32h

Therapies for Olfactory Dysfunction — an Update – Current Allergy and Asthma Reports (se o acesso a este link for pago, tente este)


M-A de 26 estudos observacionais mostrou que a perda auditiva e a perda sensorial dupla estão ligadas ao excesso de mortalidade por todas as causas e cardiovascular.

4 Fev, 2022 | 16:21h

Associations of Hearing Loss and Dual Sensory Loss With Mortality: A Systematic Review, Meta-analysis, and Meta-regression of 26 Observational Studies With 1 213 756 Participants – JAMA Otolaryngology—Head & Neck Surgery (link para o resumo – $ para o texto completo)

Entrevista com o autor: Associations of Hearing Loss and Dual Sensory Loss With Mortality


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.